Senior Research Fellow, Bond University
Dr Ray Moynihan is an award-winning journalist, author, documentary-maker and academic researcher, based in Australia with a global reputation. Reporting across print, radio, television and social media, Ray has worked at the ABC TV’s investigative program, Four Corners and the 7:30 Report, ABC Radio’s Background Briefing and The Australian Financial Review.
Since winning a Harkness Fellowship, based at Harvard University in 1999, in addition to his journalism, Ray has developed an impressive body of academic work resulting in articles in the Lancet, the New England Journal of Medicine, the Medical Journal of Australia, PLoS Medicine, and the British Medical Journal, BMJ, where he is a Visiting Editor. Since 2006 he has been a conjoint lecturer at the University of Newcastle, in Australia. Internationally recognized for his work on the business of medicine, Ray is regularly interviewed by media globally, and invited to give presentations at universities, conferences and workshops around the world.
Ray is currently a Senior Research Fellow at Bond University, where he completed his PhD on overdiagnosis. In recent years he has published or broadcast his stories in The Australian, Crikey.com, ABC Radio National, ABC’s The Drum online, and The Saturday Paper.
The winner of many awards for his investigative journalism, Ray’s 2005 book Selling Sickness was described in the New York Times as a “compelling case” and has been translated into a dozen languages. His fourth book, Sex, Lies & Pharmaceuticals was released globally in late 2010 and is generating widespread interest internationally.
How to rein in the widening disease definitions that label more healthy people as sick
May 16, 2017 17:01 pm UTC| Insights & Views Health
In the early 1990s a small meeting of experts, part-funded by drug companies, decided on a new definition of the bone condition osteoporosis. Historically, the label was limited to people who had fractures, but with the...
Drug companies are buying doctors – for as little as a $16 meal
Jun 23, 2016 09:34 am UTC| Insights & Views Business Law
An important new study in the United States has found doctors who receive just one cheap meal from a drug company tend to prescribe a lot more of that companys products. The damming findings demonstrate the value of new...
‘We have thousands of Modis’: the secret behind the BJP’s enduring success in India